| Active-Ingredient | Gemcitabine |
|---|---|
| Indication | Ovarian cancer, Head and neck cancer, Cervical cancer |
| Manufacturers | Fresenius Kabi India Pvt.Ltd. |
| Packaging | 1 Injection in 1 vial |
| Strength | 200mg |
| Drug Class | Antimetabolite / Nucleoside Metabolic Inhibitor |
| Dosage Form | Injection (Lyophilized Powder for Solution or Concentrate) |
| Delivery-Time | 6 To 15 days |
No key features available.
